{"id":561513,"date":"2026-07-04T03:00:00","date_gmt":"2026-07-04T01:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/phase-iii-trial-of-temporary-treatment-with-bepirovirsen-was-successful\/"},"modified":"2026-07-15T13:46:43","modified_gmt":"2026-07-15T11:46:43","slug":"phase-iii-trial-of-temporary-treatment-with-bepirovirsen-was-successful","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/phase-iii-trial-of-temporary-treatment-with-bepirovirsen-was-successful\/","title":{"rendered":"Phase III Trial of Temporary Treatment with Bepirovirsen Was Successful"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Hepatitis B is the most common form of viral hepatitis worldwide\u2014dreaded complications include liver cirrhosis and hepatocellular carcinoma (HCC). Treatment with Bepirovirsen, an antisense oligonucleotide that targets mRNAs of the hepatitis B virus (HBV), has the potential to lead to a functional cure in chronic hepatitis B \u2014according to a conclusion from the international B-Well study program, which examined adults with non-cirrhotic chronic HBV infection.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fphase-iii-trial-of-temporary-treatment-with-bepirovirsen-was-successful%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Hepatitis B is the most common form of viral hepatitis worldwide\u2014dreaded complications include liver cirrhosis and hepatocellular carcinoma (HCC). Treatment with Bepirovirsen, an antisense oligonucleotide that targets mRNAs of the&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fphase-iii-trial-of-temporary-treatment-with-bepirovirsen-was-successful%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":561515,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Chronic Hepatitis B: Is a Cure in Sight?  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11513,11297,11406,11503],"tags":[98656,98652,98650,15692,15690,13563,24755,15904,98659,58522,98655,77868],"powerkit_post_featured":[],"class_list":["post-561513","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-congress-reports","category-general-internal-medicine","category-infectiology","category-studies","tag-antisense-oligonucleotide","tag-b-well","tag-bepiroviruses","tag-cirrhosis-of-the-liver","tag-hbv-en","tag-hcc-en","tag-hepatitis-b-en","tag-hepatocellular-carcinoma","tag-non-cirrhotic-hbv-infection","tag-phase-iii-study","tag-study-program","tag-viral-hepatitis","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-27 18:53:15","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":561517,"slug":"letude-de-phase-iii-portant-sur-un-traitement-de-duree-limitee-par-les-bepirovirs-sest-deroulee-avec-succes","post_title":"L'\u00e9tude de phase III portant sur un traitement de dur\u00e9e limit\u00e9e par les b\u00e9pirovirs s'est d\u00e9roul\u00e9e avec succ\u00e8s","href":"https:\/\/medizinonline.com\/fr\/letude-de-phase-iii-portant-sur-un-traitement-de-duree-limitee-par-les-bepirovirs-sest-deroulee-avec-succes\/"},"it_IT":{"locale":"it_IT","id":561524,"slug":"lo-studio-di-fase-iii-sulla-terapia-a-durata-limitata-con-bepirovirsi-ha-avuto-esito-positivo","post_title":"Lo studio di fase III sulla terapia a durata limitata con bepirovirsi ha avuto esito positivo","href":"https:\/\/medizinonline.com\/it\/lo-studio-di-fase-iii-sulla-terapia-a-durata-limitata-con-bepirovirsi-ha-avuto-esito-positivo\/"},"pt_PT":{"locale":"pt_PT","id":561529,"slug":"o-ensaio-clinico-de-fase-iii-sobre-a-terapia-de-duracao-limitada-com-bepirovirsen-decorreu-com-sucesso","post_title":"O ensaio cl\u00ednico de Fase III sobre a terapia de dura\u00e7\u00e3o limitada com bepirovirsen decorreu com sucesso","href":"https:\/\/medizinonline.com\/pt-pt\/o-ensaio-clinico-de-fase-iii-sobre-a-terapia-de-duracao-limitada-com-bepirovirsen-decorreu-com-sucesso\/"},"es_ES":{"locale":"es_ES","id":561539,"slug":"el-ensayo-de-fase-iii-sobre-el-tratamiento-de-duracion-limitada-con-bepirovirsen-ha-tenido-un-resultado-satisfactorio","post_title":"El ensayo de fase III sobre el tratamiento de duraci\u00f3n limitada con bepirovirsen ha tenido un resultado satisfactorio","href":"https:\/\/medizinonline.com\/es\/el-ensayo-de-fase-iii-sobre-el-tratamiento-de-duracion-limitada-con-bepirovirsen-ha-tenido-un-resultado-satisfactorio\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=561513"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561513\/revisions"}],"predecessor-version":[{"id":561516,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/561513\/revisions\/561516"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/561515"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=561513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=561513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=561513"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=561513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}